Novel roles of 1α,25(OH)2D3 on DNA repair provide new strategies for breast cancer treatment

Journal of Steroid Biochemistry and Molecular Biology

Volumn 144, Issue PART A, 2014, Pages 59-64

  Gonzalo, Susana ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

53BP1; BRCA1; Breast cancer; Cathepsin L; DNA repair; Vitamin D

Indexed keywords

53BP1 PROTEIN; BRCA1 PROTEIN; CALCITRIOL; CATHEPSIN L; CYSTEINE PROTEINASE INHIBITOR; LAMIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 2; PROTEIN; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; BIOLOGICAL MARKER; DNA;

ARTICLE; BREAST CANCER; CANCER PROGNOSIS; CANCER THERAPY; CELL PROLIFERATION; DNA DAMAGE; DNA END JOINING REPAIR; DNA REPAIR; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME MECHANISM; GENOMIC INSTABILITY; GROWTH DISORDER; HUMAN; HUMAN CELL; IONIZING RADIATION; MEMBRANE STABILIZATION; PHASE 2 CLINICAL TRIAL (TOPIC); PROTEIN DEGRADATION; PROTEIN DEPLETION; TRIPLE NEGATIVE BREAST CANCER; GENETIC IDENTIFICATION; NONHUMAN; REVIEW;

1Α,25(OH)(2)D(3); 53BP1; BRCA1; BREAST CANCER; CATHEPSIN L; DNA REPAIR; VITAMIN D;

BREAST NEOPLASMS; DNA DAMAGE; DNA REPAIR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; VITAMIN D;

EID: 84906789805     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2013.09.009     Document Type: Review

References (50)

1. A. Jemal, and M.M. Center et al. Global patterns of cancer incidence and mortality rates and trends Cancer Epidemiol. Biomarkers Prev. 19 8 2010 1893 1907
2. W.D. Foulkes, and I.E. Smith et al. Triple-negative breast cancer N. Engl. J. Med. 363 20 2010 1938 1948
3. H. Farmer, and N. McCabe et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy Nature 434 7035 2005 917 921
4. T. Helleday, and H.E. Bryant et al. Poly(ADP-ribose) polymerase (PARP-1) in homologous recombination and as a target for cancer therapy Cell Cycle 4 9 2005 1176 1178
5. M.S. Satoh, and T. Lindahl Role of poly(ADP-ribose) formation in DNA repair Nature 356 6367 1992 356 358
6. J.C. Ame, and V. Rolli et al. PARP-2, a novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase J. Biol. Chem. 274 25 1999 17860 17868
7. S.L. Allinson, and I.I. Dianova et al. Poly(ADP-ribose) polymerase in base excision repair: always engaged, but not essential for DNA damage processing Acta Biochim. Pol. 50 1 2003 169 179
8. B.C. Woodhouse, and G.L. Dianov Poly ADP-ribose polymerase-1: an international molecule of mystery DNA Repair (Amst) 7 7 2008 1077 1086
9. A. Ashworth A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair J. Clin. Oncol. 26 22 2008 3785 3790
10. R. Scully, and S. Ganesan et al. Location of BRCA1 in human breast and ovarian cancer cells Science 272 5258 1996 123 126
11. R. Scully, and D.M. Livingston In search of the tumour-suppressor functions of BRCA1 and BRCA2 Nature 408 6811 2000 429 432
12. S. Rottenberg, and J.E. Jaspers et al. High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs Proc. Natl. Acad. Sci. U. S. A. 105 44 2008 17079 17084
13. P.C. Fong, and D.S. Boss et al. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers N. Engl. J. Med. 361 2 2009 123 134
14. M.W. Audeh, and J. Carmichael et al. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: A proof-of-concept trial Lancet 376 9737 2010 245 251
15. A. Tutt, and M. Robson et al. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: A proof-of-concept trial Lancet 376 9737 2010 235 244
16. A. Aly, and S. Ganesan BRCA1, PARP, and 53BP1: conditional synthetic lethality and synthetic viability J. Mol. Cell Biol. 3 1 2011 66 74
17. L. Cao, and X. Xu et al. A selective requirement for 53BP1 in the biological response to genomic instability induced by Brca1 deficiency Mol. Cell 35 4 2009 534 541
18. A. Bothmer, and D.F. Robbiani et al. 53BP1 regulates DNA resection and the choice between classical and alternative end joining during class switch recombination J. Exp. Med. 207 4 2010 855 865
19. P. Bouwman, and A. Aly et al. 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers Nat. Struct. Mol. Biol. 17 6 2010 688 695
20. S.F. Bunting, and E. Callen et al. 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks Cell 141 2 2010 243 254
21. J.E. Jaspers, and A. Kersbergen et al. Loss of 53BP1 causes PARP inhibitor resistance in Brca1-mutated mouse mammary tumors Cancer Discov. 3 1 2013 68 81
22. L.B. Schultz, and N.H. Chehab et al. p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks J. Cell Biol. 151 7 2000 1381 1390
23. O. Fernandez-Capetillo, and H.T. Chen et al. DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1 Nat. Cell Biol. 4 12 2002 993 997
24. B. Wang, and S. Matsuoka et al. 53BP1, a mediator of the DNA damage checkpoint Science 298 5597 2002 1435 1438
25. A. Xie, and A. Hartlerode et al. Distinct roles of chromatin-associated proteins MDC1 and 53BP1 in mammalian double-strand break repair Mol. Cell 28 6 2007 1045 1057
26. S. Difilippantonio, and E. Gapud et al. 53BP1 facilitates long-range DNA end-joining during V(D)J recombination Nature 456 7221 2008 529 533
27. N. Dimitrova, and Y.C. Chen et al. 53BP1 promotes non-homologous end joining of telomeres by increasing chromatin mobility Nature 456 7221 2008 524 528
28. X. Li, and B. Xu et al. 53BP1 functions as a tumor suppressor in breast cancer via the inhibition of NF-kappaB through miR-146a Carcinogenesis 33 12 2012 2593 2600
29. I. Gonzalez-Suarez, and A.B. Redwood et al. Loss of A-type lamins and genomic instability Cell Cycle 8 23 2009 3860 3865
30. I. Gonzalez-Suarez, and A.B. Redwood et al. Novel roles for A-type lamins in telomere biology and the DNA damage response pathway EMBO J. 28 16 2009 2414 2427
31. A.B. Redwood, and S.M. Perkins et al. A dual role for A-type lamins in DNA double-strand break repair Cell Cycle 10 15 2011 2549 2560
32. J.M. Lankelma, and D.M. Voorend et al. Cathepsin L, target in cancer treatment? Life Sci. 86 7-8 2010 225 233
33. I. Gonzalez-Suarez, and A.B. Redwood et al. A new pathway that regulates 53BP1 stability implicates Cathepsin L and vitamin D in DNA repair EMBO J. 30 16 2011 3383 3396
34. S. Alvarez-Diaz, and N. Valle et al. Cystatin D is a candidate tumor suppressor gene induced by vitamin D in human colon cancer cells J. Clin. Invest. 119 8 2009 2343 2358
35. 3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression Oncogene 19 44 2000 5091 5097
36. D.A. Grotsky, and I. Gonzalez-Suarez et al. BRCA1 loss activates cathepsin L-mediated degradation of 53BP1 in breast cancer cells J. Cell Biol. 200 2 2013 187 202
37. B.B. Zhou, and S.J. Elledge The DNA damage response: putting checkpoints in perspective Nature 408 6811 2000 433 439
38. K.K. Khanna, and S.P. Jackson DNA double-strand breaks: signaling, repair and the cancer connection Nat. Genet. 27 3 2001 247 254
39. J.H. Hoeijmakers DNA damage, aging, and cancer N. Engl. J. Med. 361 15 2009 1475 1485
40. S.P. Jackson, and J. Bartek The DNA-damage response in human biology and disease Nature 461 7267 2009 1071 1078
41. A. Ciccia, and S.J. Elledge The DNA damage response: making it safe to play with knives Mol. Cell 40 2 2010 179 204
42. C. Wyman, and R. Kanaar DNA double-strand break repair: all's well that ends well Annu. Rev. Genet. 40 2006 363 383
43. A. Shibata, and S. Conrad et al. Factors determining DNA double-strand break repair pathway choice in G2 phase EMBO J. 30 6 2011 1079 1092
44. R. Scully, and J. Chen et al. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage Cell 90 3 1997 425 435
45. R. Scully, and J. Chen et al. Association of BRCA1 with Rad51 in mitotic and meiotic cells Cell 88 2 1997 265 275
46. M.E. Moynahan, and J.W. Chiu et al. Brca1 controls homology-directed DNA repair Mol. Cell 4 4 1999 511 518
47. J.N. Snouwaert, and L.C. Gowen et al. BRCA1 deficient embryonic stem cells display a decreased homologous recombination frequency and an increased frequency of non-homologous recombination that is corrected by expression of a brca1 transgene Oncogene 18 55 1999 7900 7907
48. B.P. Schlegel, and F.M. Jodelka et al. BRCA1 promotes induction of ssDNA by ionizing radiation Cancer Res. 66 10 2006 5181 5189
49. S. Alvarez-Diaz, and M.J. Larriba et al. Vitamin D: proteases, protease inhibitors and cancer Cell Cycle 9 1 2010 32 37
50. A.S. Dusso, and A.J. Brown et al. Vitamin D Am. J. Physiol. Renal Physiol. 289 1 2005 F8 F28